• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT MEDICAL AMPLATZER PFO OCCLUDER; TRANSCATHETER SEPTAL OCCLUDER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT MEDICAL AMPLATZER PFO OCCLUDER; TRANSCATHETER SEPTAL OCCLUDER Back to Search Results
Model Number 9-PFO-025
Device Problem Biocompatibility (2886)
Patient Problems Arrhythmia (1721); Dyspnea (1816); Nausea (1970); Thrombosis/Thrombus (4440)
Event Date 05/01/2021
Event Type  Injury  
Manufacturer Narrative
The results, method, and conclusion codes along with investigation results will be provided in the final report.
 
Event Description
Clinical study: patient id: (b)(6).It was reported that on (b)(6) 2021, a 25 mm amplatzer pfo occluder was successfully implanted in a patient with preexisting conditions of tachycardia.Post-implant the patient was noted to have bleeding issues.On (b)(6) 2021, a hematoma was noted under the incision site with increasing pain.Ultrasound was performed and it was noted not to be a pressing issue.The hematoma later self-resolved on (b)(6) 2021.On (b)(6) 2021, an echocardiogram was performed and revealed a small mobile thrombus on the right atrial side of the implanted device.No intervention was performed and the thrombus was noted to have disappeared on (b)(6) 2021.On (b)(6) 2021, the patient had nausea, palpitations, and shortness of breath while driving.The patient presented to the emergency department and was diagnosed with tachycardia.The patient was given ondansetron orally and the symptoms resolved.The patient was discharged without being admitted to the hospital.There is no allegation that the cause of the tachycardia was due to the abbott device or implant procedure.No additional information was reported.
 
Manufacturer Narrative
An event of thrombus on the device, which self-resolved was reported.A more comprehensive assessment could not be performed, as the device remains implanted.Was not returned for analysis.The device history record was reviewed, to ensure that each manufacturing and inspection operation was performed, and the product met all specifications.Based on the information received, the cause of the reported incident could not be conclusively determined.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
AMPLATZER PFO OCCLUDER
Type of Device
TRANSCATHETER SEPTAL OCCLUDER
Manufacturer (Section D)
ABBOTT MEDICAL
5050 nathan lane north
plymouth MN 55442
MDR Report Key12315655
MDR Text Key266368793
Report Number2135147-2021-00326
Device Sequence Number1
Product Code MLV
UDI-Device Identifier00811806011288
UDI-Public00811806011288
Combination Product (y/n)N
PMA/PMN Number
P120021
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,health
Type of Report Initial,Followup
Report Date 09/03/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received08/12/2021
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model Number9-PFO-025
Device Catalogue Number9-PFO-025
Device Lot Number7820637
Was Device Available for Evaluation? No
Was the Report Sent to FDA? No
Date Manufacturer Received08/18/2021
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Other;
Patient Age51 YR
-
-